• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制良好的哮喘患者支气管扩张剂反应性的决定因素

Determinants of bronchodilator responsiveness in patients with controlled asthma.

作者信息

Koga Takeharu, Kamimura Tomoko, Oshita Yuichi, Narita Yuko, Mukaino Tatsuya, Nishimura Munetsugu, Mizoguchi Yusuke, Aizawa Hisamichi

机构信息

First Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.

出版信息

J Asthma. 2006 Jan-Feb;43(1):71-4. doi: 10.1080/02770900500448662.

DOI:10.1080/02770900500448662
PMID:16448969
Abstract

Short-term bronchodilator responsiveness to an inhaled ss 2 adrenergic agonist was assessed by changes in forced expiratory volume in 1 second (FEV(1)) in nonsmoking adults with controlled asthma (mild disease, 20 patients; moderate disease, 20 patients; severe disease, 18 patients). Responsiveness correlated significantly with age and with percent of predicted FEV(1) (%FEV(1)) except in patients with severe asthma, who showed significantly less responsiveness than others. Thus, responsiveness is closely associated with degree of airflow limitation in patients with controlled asthma and is significantly influenced by severity of disease and by aging.

摘要

通过测量一秒用力呼气容积(FEV(1))的变化,评估了非吸烟成年哮喘控制患者(轻度疾病20例、中度疾病20例、重度疾病18例)对吸入性β2肾上腺素能激动剂的短期支气管扩张反应性。除重度哮喘患者外,反应性与年龄和预计FEV(1)百分比(%FEV(1))显著相关,重度哮喘患者的反应性明显低于其他患者。因此,反应性与哮喘控制患者的气流受限程度密切相关,并受疾病严重程度和年龄的显著影响。

相似文献

1
Determinants of bronchodilator responsiveness in patients with controlled asthma.控制良好的哮喘患者支气管扩张剂反应性的决定因素
J Asthma. 2006 Jan-Feb;43(1):71-4. doi: 10.1080/02770900500448662.
2
Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.40岁及以上初级保健患者中慢性阻塞性肺疾病(COPD)和哮喘的误诊情况。
J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738.
3
Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD.急性支气管扩张剂反应在区分支气管哮喘和慢性阻塞性肺疾病方面价值有限。
J Asthma. 2005 Jun;42(5):367-72. doi: 10.1081/JAS-62992.
4
Determining the time to maximal bronchodilator response in asthmatic children.确定哮喘儿童达到最大支气管扩张剂反应的时间。
J Asthma. 2009 Feb;46(1):25-9. doi: 10.1080/02770900802460555.
5
The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病对支气管扩张剂的容量反应
COPD. 2008 Jun;5(3):147-52. doi: 10.1080/15412550802092928.
6
[Comparison of acute bronchodilator tests in patients with chronic obstructive lung disease and bronchial asthma].
Probl Tuberk Bolezn Legk. 2005(7):40-4.
7
High resolution CT and bronchial reversibility test for diagnosing COPD.高分辨率CT和支气管可逆性试验用于慢性阻塞性肺疾病的诊断。
Respirology. 2005 Jun;10(3):316-22. doi: 10.1111/j.1440-1843.2005.00701.x.
8
Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.在乙酰甲胆碱诱导支气管收缩后,有或没有S-沙丁胺醇预处理的情况下,左旋沙丁胺醇剂量反应的比较。
Pharmacotherapy. 2007 Sep;27(9):1231-6. doi: 10.1592/phco.27.9.1231.
9
Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.轻至极重度慢性阻塞性肺疾病患者常规沙丁胺醇可逆性试验后的气流和容积反应
Respir Med. 2007 Jun;101(6):1355-62. doi: 10.1016/j.rmed.2006.09.024. Epub 2006 Nov 13.
10
Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.支气管收缩和舒张反应对胸腔气体压缩量的依赖性。
Respirology. 2014 Oct;19(7):1040-5. doi: 10.1111/resp.12349. Epub 2014 Jul 14.

引用本文的文献

1
Prevalence of Bronchodilator Responsiveness: A Comparison of Old Versus New Criteria.支气管扩张剂反应性的流行率:新旧标准的比较。
Respir Care. 2024 Sep 26;69(10):1266-1274. doi: 10.4187/respcare.11603.
2
Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.支气管扩张剂反应性的定义:2005 年和 2021 年 ERS/ATS 标准在哮喘以及慢性阻塞性肺疾病患者中的应用。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 17;17:2623-2633. doi: 10.2147/COPD.S385733. eCollection 2022.
3
The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-Analysis.
β-2肾上腺素能受体基因多态性对哮喘患者沙丁胺醇治疗的影响:系统评价与Meta分析方案
JMIR Res Protoc. 2019 Sep 16;8(9):e14759. doi: 10.2196/14759.
4
Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents.市中心儿童和青少年中难治性哮喘的鉴别特征。
J Allergy Clin Immunol. 2016 Oct;138(4):1030-1041. doi: 10.1016/j.jaci.2016.06.059.
5
Magnesium nebulization utilization in management of pediatric asthma (MagNUM PA) trial: study protocol for a randomized controlled trial.镁雾化吸入治疗小儿哮喘(MagNUM PA)试验:一项随机对照试验的研究方案
Trials. 2016 May 24;17(1):261. doi: 10.1186/s13063-015-1151-x.
6
Asthma outcomes: pulmonary physiology.哮喘结局:肺生理学。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S65-87. doi: 10.1016/j.jaci.2011.12.986.
7
The role of inhaled and/or nasal corticosteroids on the bronchodilator response.吸入性和/或鼻用皮质类固醇对支气管扩张剂反应的作用。
Korean J Pediatr. 2010 Nov;53(11):951-6. doi: 10.3345/kjp.2010.53.11.951. Epub 2010 Nov 30.